-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Buy on Starling Oncology, Maintains $10 Price Target

Benzinga·11/09/2026 10:12:51
Listen to the news
BTIG analyst David Larsen reiterates Starling Oncology (NASDAQ:STLN) with a Buy and maintains $10 price target.